Cataract surgery product manufacturer Rayner has now sold five million RayOne lenses and 11 million lenses made from RayAcryl Rayner’s proprietary hydrophilic acrylic material.
RayOne is Rayner’s fully-preloaded intraocular lens (IOL) injection system said to provide smooth, consistent rolling and delivery of the IOL via micro incision. All hydrophobic and hydrophilic IOLs in the RayOne range come with a single fully-preloaded and repeatable injector, designed to minimise errors, reduce risk of contamination and minimise lens damage.
The range offers spheric, aspheric and toric lens options to suit a wide range of patients.
“As we celebrate our five million milestone, we’d like to extend our gratitude to the clinicians and surgeons we partner with, who trust Rayner to provide the best visual outcomes for their patients. We look forward to continuing to deliver our IOL solutions to provide a better operating theatre experience,” Mr Tim Clover, Rayner CEO, said.
The milestone comes during an important year for cataract surgery, with Rayner marking the 75th anniversary of the first implantation of an IOL in 2024.
As the manufacturer of the first IOL, designed by Sir Harold Ridley, Rayner is committed to evolving and developing its product offering.
The company recently announced its acquisition of the Swiss-based Sophi phaco emulsification machine, enabling provision of a full offering of products for cataract surgery.
For more information regarding the RayOne family of lenses visit RayOne fully preloaded IOL systems.
More reading
Rayner continues sustainability push with updated packaging
Rayner develops online clinical program Peer2Peer
Rayner announces acquisition of Sophi phaco system
